ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

PCSA Processa Pharmaceuticals Inc

2.14
-0.12 (-5.31%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Processa Pharmaceuticals Inc PCSA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.12 -5.31% 2.14 13:00:00
始値 安値 高値 終値 前日終値
2.30 2.15 2.30 2.17 2.26
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3021:00GLOBEProcessa Pharmaceuticals Names Dr. Steven Cha Senior Vice..
2024/4/1121:00GLOBEProcessa Pharmaceuticals Presents Two Abstracts at the AACR..
2024/3/2821:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest Biotech..
2024/3/2521:15GLOBEProcessa Pharmaceuticals to Present Data at the American..
2024/2/2207:25EDGAR2Form 8-K - Current report
2024/2/2122:15GLOBEProcessa Pharmaceuticals to Present at the 2024 BIO CEO &..
2024/2/1503:00GLOBEProcessa Pharmaceuticals to Present at The Winter Wrap-Up..
2024/2/0622:30EDGAR2Form 8-K - Current report
2024/2/0622:30GLOBEProcessa Pharmaceuticals Regains Compliance with Nasdaq..
2024/2/0208:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0206:22GLOBEProcessa Pharmaceuticals Announces Closing of $7.0 Million..
2024/2/0106:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3100:46EDGAR2Form 8-K - Current report
2024/1/3006:15EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2024/1/2914:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/1/2623:04GLOBEProcessa Pharmaceuticals Announces Pricing of $7.0 Million..
2024/1/2522:35EDGAR2Form 8-K - Current report
2024/1/2522:30GLOBEProcessa Pharmaceuticals Announces Successful Completion of..
2024/1/1922:00EDGAR2Form 8-K - Current report
2024/1/1921:45GLOBEProcessa Pharmaceuticals Announces Expansion of NGC-Cap..
2024/1/1822:30EDGAR2Form 8-K - Current report
2024/1/1821:45GLOBEProcessa Pharmaceuticals to Effect a 1-for-20 Reverse Stock..
2024/1/0906:30EDGAR2Form 8-K - Current report
2024/1/0307:06GLOBEProcessa Pharmaceuticals to Present at the Biotech Showcase..
2023/12/2922:55EDGAR2Form S-1 - General form for registration of securities under..
2023/12/1923:00EDGAR2Form 8-K - Current report
2023/12/1923:00GLOBEProcessa Pharmaceuticals Provides Interim Analysis from..
2023/12/1323:00GLOBEProcessa Pharmaceuticals Announces Successful Phase 2..
2023/12/0607:18EDGAR2Form 8-K - Current report
2023/11/3022:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest..
2023/11/2922:15GLOBEProcessa Pharmaceuticals Issues Letter to Shareholders..
2023/11/1705:10EDGAR2Form 8-K - Current report
2023/11/1601:30EDGAR2Form 8-K - Current report
2023/11/1406:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1404:45EDGAR2Form 8-K - Current report
2023/11/1403:40GLOBEProcessa Pharmaceuticals, Inc. Mourns the Sudden Passing of..
2023/11/0922:15GLOBEProcessa Pharmaceuticals to Present at the 20th Orphan Drugs..
2023/11/0121:15GLOBEProcessa Pharmaceuticals Announces Formation of Oncology..
2023/10/1622:15EDGAR2Form 8-K - Current report
2023/10/1402:08GLOBEProcessa Pharmaceuticals to Present at the ThinkEquity..
2023/10/1307:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1307:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1307:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1306:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1106:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1106:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1105:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1105:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0523:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/10/0523:00EDGAR2Form DEF 14A - Other definitive proxy statements

最近閲覧した銘柄

Delayed Upgrade Clock